Literature DB >> 21303485

Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity.

Kenichi Osada1, Hiroshi Oka, Tatsuya Isomura, Ikuro Nakamura, Keiichiro Tominaga, Shinobu Takahashi, Ayako Kojima, Kusuki Nishioka.   

Abstract

AIM: To perform a psychometric assessment of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ).
METHODS: Data for the psychometric assessment were collected from Japanese fibromyalgia (FM) patients who visited a clinic. Analyses were performed to examine the reliability and validity of the JFIQ.
RESULTS: A total of 56 patients were included in the analysis. There was no remarkable floor or ceiling effect for the JFIQ item or total scores. In the analysis of reproducibility, the interclass correlation coefficients of each item score and total score ranged from 0.61 to 0.95. Cronbach's alpha coefficient was 0.92. For the concurrent validity, the total score and most of the item scores correlated to every domain of Short Form-36 or Beck Depression Inventory-II to a moderate or great extent. The results of the known-group comparisons indicated that the total score tended to increase with the increase in severity of FM and pain (P-values for trend < 0.05).
CONCLUSION: This psychometric assessment demonstrated good reliability and validity of the JFIQ for use with Japanese FM patients. In the future, we expect that this questionnaire will be used in clinical studies and medical practice, and will be beneficial in the development of new therapies as well as for the comprehensive evaluation of patients' conditions in Japan.
© 2011 The Authors. International Journal of Rheumatic Diseases © 2011 Asia Pacific League of Associations for Rheumatology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21303485     DOI: 10.1111/j.1756-185X.2010.01585.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  11 in total

1.  Evaluation of invasiveness in single-site laparoscopic colectomy, using "the PainVision™ system" for quantitative analysis of pain sensation.

Authors:  Masayuki Hiraki; Ichiro Takemasa; Mamoru Uemura; Naotsugu Haraguchi; Junichi Nishimura; Taishi Hata; Tsunekazu Mizushima; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Surg Endosc       Date:  2014-07-16       Impact factor: 4.584

2.  Validation of an adapted arabic version of fibromyalgia syndrome impact questionnaire.

Authors:  Mai Abd El-Naby; Mohamed Ahmed Hefny; Ayman Ekram Fahim; Magdy Ahmed Awadalla
Journal:  Rheumatol Int       Date:  2013-05-17       Impact factor: 2.631

3.  Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P).

Authors:  Ali Bidari; Morteza Hassanzadeh; Mohamad-Farzam Mohabat; Elham Talachian; Effat Merghati Khoei
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

4.  Effects of xenon irradiation of the stellate ganglion region on fibromyalgia.

Authors:  Fukami Nakajima; Akihiro Komoda; Satoko Aratani; Hidetoshi Fujita; Mariko Kawate; Kou Nakatani; Masako Akiyama; Koshi Makita; Toshihiro Nakajima
Journal:  J Phys Ther Sci       Date:  2015-01-09

5.  A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.

Authors:  Masato Murakami; Kenichi Osada; Hiromichi Mizuno; Toshimitsu Ochiai; Levent Alev; Kusuki Nishioka
Journal:  Arthritis Res Ther       Date:  2015-08-22       Impact factor: 5.156

6.  Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy.

Authors:  Yoichiro Yoshida; Ai Mogi; Teppei Yamada; Naoya Aisu; Taisuke Matsuoka; Daibo Kojima; Syu Tanimura; Tomoko Koganemaru; Mayumi Oda; Mahiru Fukuda; Fumiaki Kiyomi; Keita Noda; Keiji Hirata; Yuichi Yamashita
Journal:  Springerplus       Date:  2015-12-30

7.  Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration.

Authors:  Yoichiro Yoshida; Ai Mogi; Naoya Aisu; Teppei Yamada; Taisuke Matsuoka; Daibo Kojima; Toshiyuki Mera; Tomoko Koganemaru; Fumiaki Kiyomi; Keita Noda; Yasushi Takamatsu; Kazuo Tamura; Yuichi Yamashita; Suguru Hasegawa
Journal:  Springerplus       Date:  2016-10-26

8.  A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.

Authors:  Hiroyoshi Ohta; Hiroshi Oka; Chie Usui; Masayuki Ohkura; Makoto Suzuki; Kusuki Nishioka
Journal:  Arthritis Res Ther       Date:  2012-10-12       Impact factor: 5.156

Review 9.  Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II.

Authors:  Yuan-Pang Wang; Clarice Gorenstein
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

10.  Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan.

Authors:  Kenji Miki; Masato Murakami; Hiroshi Oka; Kaname Onozawa; Sadahiro Yoshida; Kenichi Osada
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.